Page last updated: 2024-12-08

4-nitrophenylphosphorylcholine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

p-nitrophenylphosphocholine : A phosphocholine that is the 4-nitrophenyl ester of choline phosphate. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID445100
CHEBI ID55394
SCHEMBL ID4542384
MeSH IDM0103975

Synonyms (17)

Synonym
p-nitrophenyl-phosphocholine
1DL7
4-nitrophenyl 2-(trimethylammonio)ethyl phosphate
4-nitrophenylphosphorylcholine
2-{[hydroxy(4-nitrophenoxy)phosphoryl]oxy}-n,n,n-trimethylethanaminium
npcc
nppc
CHEBI:55394 ,
phosphocholine 4-nitrophenyl ester
nitrophenylphosphocholine
nitrophenylphosphorylcholine
p-nitrophenylphosphocholine
2-[hydroxy-(4-nitrophenoxy)phosphoryl]oxyethyl-trimethylazanium
EPITOPE ID:122665
SCHEMBL4542384
2-{[(s)-hydroxy(4-nitrophenoxy)phosphoryl]oxy}-n,n,n-trimethylethanaminium
Q27104815
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
epitopeThe biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
haptenAny substance capable of eliciting an immune response only when attached to a large carrier such as a protein. Examples include dinitrophenols; oligosaccharides; peptides; and heavy metals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
phosphocholinesAny compound having phosphocholine as part of its structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain H, Protein (antibody M3c65 (heavy Chain))Mus musculus (house mouse)Kd0.32000.32000.32000.3200AID977611
Chain L, Protein (antibody M3c65 (light Chain))Mus musculus (house mouse)Kd0.32000.32000.32000.3200AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2000The Journal of experimental medicine, Jun-19, Volume: 191, Issue:12
The structural basis of repertoire shift in an immune response to phosphocholine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (40.00)18.7374
1990's8 (26.67)18.2507
2000's4 (13.33)29.6817
2010's2 (6.67)24.3611
2020's4 (13.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.49 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (96.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]